Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07424742

Graftless TSFE Via Self-tapping Implants

Transcrestal Graftless Schneiderian Membrane Elevation by Self-tapping Dental Implant

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Sana'a University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This prospective clinical trial aims to evaluate the efficiency, safety, and reliability of a minimally invasive graftless transcrestal sinus lifting approach with simultaneous dental implant placement in patients with edentulous posterior maxilla and limited residual bone height. The study investigates bone formation beneath the Schneiderian membrane, implant stability, osseointegration, and long-term implant survival.

Detailed description

This prospective clinical study evaluates a minimally invasive graftless sinus lifting technique using a transcrestal approach with simultaneous implant placement in the posterior maxilla. The procedure involves tenting the Schneiderian membrane without the use of grafting material, relying on blood clot formation and natural bone regeneration beneath the elevated membrane. Radiographic and clinical evaluations will be performed preoperatively, immediately postoperatively, and at 6 months to assess bone formation, implant stability, and osseointegration.

Conditions

Interventions

TypeNameDescription
PROCEDUREGraftless Transcrestal Sinus Membrane Elevation with Simultaneous Implant PlacementA minimally invasive transcrestal approach for sinus membrane elevation without graft material, followed by simultaneous placement of a 10 mm length and 4-4.5 mm diameter dental implant in the posterior maxilla with residual bone height of approximately 5 mm.

Timeline

Start date
2024-09-09
Primary completion
2026-03-03
Completion
2026-09-09
First posted
2026-02-20
Last updated
2026-02-20

Locations

1 site across 1 country: Yemen

Source: ClinicalTrials.gov record NCT07424742. Inclusion in this directory is not an endorsement.